Doron Therapeutics begins Phase 3 study of treatment for osteoarthritis of the knee | North Carolina Biotechnology Center

Osteoarthritis of the Knee: A Complex Condition

About one in 10 Americans will experience knee pain, swelling, and stiffness, with the most common diagnosis being osteoarthritis (OA) of the knee.

OA of the knee is a complex condition caused by multiple factors, including inflammation and wear and tear on the joints, leading to the erosion of the cartilage "cushion" and painful bone-on-bone contact.

Currently, there is no cure for OA of the knee, with short-term measures such as oral pain medications, physical therapy, or steroid injections providing temporary relief.

Longer-term alternatives to surgery are limited, especially as the condition worsens, with age and obesity being risk factors.

Doron Therapeutics has begun a Phase 3 study of a treatment for osteoarthritis of the knee.

No cure yet for OA of the knee.

Author's summary: Doron Therapeutics starts Phase 3 study for OA knee treatment.

more

NC Biotech NC Biotech — 2025-10-16

More News